ArticleOncology letters2025

Comprehensive pan-cancer analysis reveals ubiquitin-conjugating enzyme 2T as a potential biomarker for prognosis and cancer immunity.

Zhou Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.